Evidence map›Paper›PMID 34159509›Full record

ArticleJournal of clinical immunology2021

ALPK1 Gene Mutations Drive Autoinflammation with Ectodermal Dysplasia and Progressive Vision Loss.

Yvan Jamilloux, Thibaud Mathis, Olivier Grunewald, Hélène Dollfuss, Thomas Henry, Pascal Sève, Isabelle Meunier

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yvan JamillouxInternal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, 103 grande rue de la Croix-Rousse, 69004, Lyon, France. yvan.jamilloux@chu-lyon.fr.ORCID http://orcid.org/0000-0001-5249-3650
Thibaud MathisOphthalmology, University Hospital Croix-Rousse, UMR-CNRS 5510 Matéis, Hospices Civils de Lyon, University Lyon 1, Lyon, France.
Olivier GrunewaldUniv. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France.
Hélène DollfussCentre Des Affections Rares en Génétique Ophtalmologique (CARGO), Strasbourg University Hospitals, Strasbourg, France.
Thomas HenryCentre International de Recherche en Infectiologie (CIRI), Inserm U1111, Université Claude Bernard-Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.
Pascal SèveInternal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, 103 grande rue de la Croix-Rousse, 69004, Lyon, France.
Isabelle MeunierInstitute for Neurosciences of Montpellier U1051, National Center in Rare Diseases, Genetics of Sensory Diseases, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Université Claude Bernard Lyon 1 · FRInserm · FRUniversité de Montpellier · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal Cortex HormonesAdultAntirheumatic AgentsAzathioprineDermatologic AgentsEctodermal DysplasiaHereditary Autoinflammatory DiseasesHumansImmunosuppressive AgentsInfliximabMaleMutationProtein KinasesVision DisordersAdrenal Cortex HormonesALPK1 protein, humanAntirheumatic AgentsAzathioprineDermatologic AgentsImmunosuppressive AgentsInfliximabProtein Kinases

Identifiers

PMID34159509
OpenAlexW3173431317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.